Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia: a comment

被引：0
|
作者：
Effat Davoudi-Monfared
Maryam Taghizadeh-Ghehi
机构：
[1] Tehran University of Medical Sciences,Department of Clinical Pharmacy, Faculty of Pharmacy
[2] Tehran University of Medical Sciences,Research Center for Rational Use of Drugs
来源：
International Journal of Clinical Pharmacy | 2019年 / 41卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：621 / 622
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness analysis of linezolid versus vancomycin in the treatment of ventilator-associated pneumonia in Spain
    Grau, S
    Alvarez-Lerma, F
    De la Fuente, S
    Neipp, R
    Rubio-Terres, C
    VALUE IN HEALTH, 2004, 7 (06) : 759 - 759
  • [32] A Cost-Effectiveness Analysis Of Low-Dose Theophylline In The Treatment Of Status Asthmaticus In Children
    Myers, J. A.
    O'Hagan, A.
    Bickel, S.
    Morton, R.
    Eid, N. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [33] Low-dose versus high-dose colistin: cost saving, less toxicity
    Reactions Weekly, 2018, 1717 (1) : 7 - 7
  • [34] LONG-TERM OUTCOMES OF LENACAPAVIR PLUS OPTIMIZED BACKGROUND REGIMEN VERSUS OTHER TREATMENTS FOR MULTI-DRUG RESISTANT HIV VIA A COST-EFFECTIVENESS MODEL
    Vardanega, V.
    Rawlinson, W.
    Francis-Graham, S.
    Mezzio, D.
    Eddowes, L. A.
    VALUE IN HEALTH, 2022, 25 (07) : S379 - S379
  • [35] COST-EFFECTIVENESS OF LINEZOLID VERSUS VANCOMYCIN IN THE TREATMENT OF VENTILATOR ASSOCIATED PNEUMONIA IN JAMAICA
    Garita, M.
    Nicholson, A.
    Cuesta, G.
    Mould, J.
    VALUE IN HEALTH, 2013, 16 (07) : A352 - A352
  • [36] Cost-Effectiveness Analysis of New Beta-Lactam Beta-Lactamase Inhibitor Antibiotics Versus Colistin for the Treatment of Carbapenem-Resistant Infections
    Bianchini, Monica L.
    Jeffres, Meghan N.
    Campbell, Jonathan D.
    HOSPITAL PHARMACY, 2022, 57 (01) : 93 - 100
  • [37] Low-dose versus medium-dose aspirin for preeclampsia prevention in pregnancy: a cost-effectiveness analysis
    Saito, Tanya
    Speranza, Rosa
    Vinson, Abbie
    Hersh, Alyssa R.
    Caughey, Aaron B.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : S144 - S145
  • [38] Intravenous colistin for the treatment of multi-drug resistant, gram-negative infection in the pediatric burn population
    Goverman, Jeremy
    Weber, Joan M.
    Keaney, Timothy J.
    Sheridan, Robert L.
    JOURNAL OF BURN CARE & RESEARCH, 2007, 28 (03): : 421 - 426
  • [39] Comparison of colistin monotherapy and non-colistin combinations in the treatment of multi-drug resistant Acinetobacter spp. bloodstream infections: A Multicenter retrospective analysis
    Balkan, Ilker Inanc
    Batirel, Ayse
    Karabay, Oguz
    Agalar, Canan
    Akalin, Serife
    Alici, Ozlem
    Alp, Emine
    Altay, Fatma Aybala
    Altin, Nilgun
    Arslan, Ferhat
    Aslan, Turan
    Bekiroglu, Nural
    Cesur, Salih
    Celik, Aygul Dogan
    Dogan, Mustafa
    Durdu, Bulent
    Duygu, Fazilet
    Engin, Aynur
    Engin, Derya Ozturk
    Gonen, Ibak
    Guciu, Ertugrul
    Guven, Tumer
    Hatipogiu, Cigdem Ataman
    Hosoglu, Salih
    Karahocagil, Mustafa Kasim
    Kilic, Aysegul Ulu
    Ormen, Bahar
    Ozdemir, Davut
    Ozer, Serdar
    Oztoprak, Nefise
    Sezak, Nurbanu
    Turhan, Vedat
    Turker, Nesrin
    Yilmaz, Hava
    INDIAN JOURNAL OF PHARMACOLOGY, 2015, 47 (01) : 95 - 100
  • [40] Incorporating social justice and stigma in cost-effectiveness analysis: drug-resistant tuberculosis treatment
    Zwerling, A.
    Dowdy, D.
    von Delft, A.
    Taylor, H.
    Merritt, M. W.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2017, 21 (11) : S69 - +
12345